AB 1460 Remains an Active Two-Year Bill in the Senate, but the Official Record Shows No 2026 Action
Correction (July 15, 2026): California's official bill record classifies AB 1460 as an active bill in the Senate committee process, but it records no 2026 hearing or other 2026 action. The last history action remains July 16, 2025, when the Senate Health Committee postponed the hearing; prior June 25 and July 2 hearings were canceled at the author's request.
The bill would restrict manufacturer interference with covered entities' delivery of 340B drugs through contract pharmacies, so it remains relevant to FQHC pharmacy strategy, but teams should not plan around an asserted 2026 return until the Legislature posts a new action.
Key takeaways
- Official status: active bill in the Senate committee process; last action was a July 16, 2025 hearing postponement.
- No 2026 action is recorded as of July 15; retire the unsupported expectation that the bill already returned this year.
- Continue monitoring because contract-pharmacy protection remains material to FQHC 340B access, but wait for a posted legislative action.
Primary source
California Legislative InformationSource packet
This story's primary source + 4 related tracked stories with theirs — one print-ready digest for your team or board packet.
Free — subscribes you to the weekly Intel Brief. Individual sources are always clickable above, no email needed.
FQHC Talent. (2025, July 16). AB 1460 Remains an Active Two-Year Bill in the Senate, but the Official Record Shows No 2026 Action. Primary source: California Legislative Information. Retrieved July 28, 2026, from https://www.fqhctalent.com/intel/ab-1460-340b-contract-pharmacy-2026
More in Legislation
Jul 24
HHS strips disparate-impact liability out of its Title VI regulations — final rule, effective the day it published, no comment period; 45 CFR part 80 binds every Section 330 grantee
Jul 22
Arkansas AG sues 13 drugmakers + a data firm over 340B — the first time a state goes on OFFENSE under its own 340B shield law, with the state health-center association standing beside him
Jul 16
CY2027 Physician Fee Schedule Proposed Rule Lands — CMS Proposes the FQHC PPS Base Rate Rise to $212.91 (+2.5%), Comments Close September 14
Jul 1
8th Circuit Rejects Novartis's Bid to Block Missouri's 340B Contract-Pharmacy Law — Another State Shield Survives a Manufacturer Challenge